Ibrutinib (PCI-32765) in Waldenstrom's Macroglobulinemia
Clinical trial NCT01614821 · COMPLETED
Trial details
- NCT number
- NCT01614821
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-01
- Primary completion
- 2016-09-09
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.